JPS55102512A - Blend and its administration - Google Patents

Blend and its administration

Info

Publication number
JPS55102512A
JPS55102512A JP519880A JP519880A JPS55102512A JP S55102512 A JPS55102512 A JP S55102512A JP 519880 A JP519880 A JP 519880A JP 519880 A JP519880 A JP 519880A JP S55102512 A JPS55102512 A JP S55102512A
Authority
JP
Japan
Prior art keywords
water
blend
administration
prostaglandin
intravaginal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP519880A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0140013B2 (en, 2012
Inventor
Yohanson Oroofu
Ibaaru Urumusuten Urufu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Perstorp AB
Original Assignee
Perstorp AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perstorp AB filed Critical Perstorp AB
Publication of JPS55102512A publication Critical patent/JPS55102512A/ja
Publication of JPH0140013B2 publication Critical patent/JPH0140013B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP519880A 1979-01-29 1980-01-18 Blend and its administration Granted JPS55102512A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7900737A SE431821B (sv) 1979-01-29 1979-01-29 Lagringsstabilt, prostaglandininnehallande medicinskt preparat

Publications (2)

Publication Number Publication Date
JPS55102512A true JPS55102512A (en) 1980-08-05
JPH0140013B2 JPH0140013B2 (en, 2012) 1989-08-24

Family

ID=20337129

Family Applications (1)

Application Number Title Priority Date Filing Date
JP519880A Granted JPS55102512A (en) 1979-01-29 1980-01-18 Blend and its administration

Country Status (10)

Country Link
US (1) US4352790A (en, 2012)
JP (1) JPS55102512A (en, 2012)
BE (1) BE881351A (en, 2012)
DE (1) DE3001454A1 (en, 2012)
DK (2) DK160739C (en, 2012)
FR (1) FR2447191A1 (en, 2012)
GB (1) GB2041220B (en, 2012)
NL (1) NL190693C (en, 2012)
NO (1) NO153520C (en, 2012)
SE (2) SE431821B (en, 2012)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5731607A (en) * 1980-06-20 1982-02-20 Crinos Industria Farmaco Spermicidal composition for local use
JPH01221318A (ja) * 1988-03-01 1989-09-04 Masao Igarashi ダナゾール含有の局所投与製剤
WO1993008804A1 (en) * 1991-11-08 1993-05-13 Kyoto Pharmaceutical Industries, Ltd. Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3071006D1 (en) * 1979-03-21 1985-09-26 Nat Res Dev Composition for the controlled release of an active substance and process for its preparation
US5079009A (en) * 1979-03-21 1992-01-07 National Research Development Corporation Controlled release compositions including polyethylene oxide with urethane cross-linking
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
AU546872B2 (en) * 1982-06-16 1985-09-26 Unilever Plc Skin treatment compositions containing a fatty acid or ester
US4675182A (en) * 1983-02-12 1987-06-23 Bayer Aktiengesellschaft Complexes of prostaglandins
DE3307816A1 (de) * 1983-03-02 1984-09-06 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin-haltiges pharmazeutisches praeparat und seine herstellung
GB8403360D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
DE3428264A1 (de) * 1984-07-27 1986-03-06 Schering Ag Gelhaltige pharmazeutische zubereitungen
IE59361B1 (en) * 1986-01-24 1994-02-09 Akzo Nv Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension
JPH03220201A (ja) * 1988-11-18 1991-09-27 Eisai Co Ltd プロスタグランジン類と多糖類の結合体
CH678697A5 (en, 2012) * 1989-04-03 1991-10-31 Warner Lambert Co
US6946442B2 (en) * 1994-11-30 2005-09-20 Asif Syed Ahmed Method of hastening cervical ripening
JPH11506100A (ja) * 1995-06-01 1999-06-02 ジー．ディー．サール アンド カンパニー ミソプロストールの安定化された分散系
AU742787B2 (en) 1997-07-09 2002-01-10 Androsolutions, Inc. Improved methods and compositions for treating male erectile dysfunction
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
FR2766709B1 (fr) 1997-07-31 2000-04-07 Dominique Cingotti Procede pour la preparation d'un extrait de principes actifs sous forme de microgranules a base de fibres alimentaires entierement solubles destines a differentes formes galeniques
US6031002A (en) * 1998-05-01 2000-02-29 Michael Ebert Method for enhancing female sexual response and a composition therefor
US5891915A (en) * 1998-05-01 1999-04-06 Wysor; Michael S. Method for enhancing female sexual response and an ointment therefor
US20070191320A1 (en) * 1998-12-10 2007-08-16 Nexmed Holdings, Inc. Methods of treatment for female sexual arousal disorder
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
GR1004266B (el) * 2001-04-30 2003-06-18 Ηλιας Κ. Παπαδοπουλος Φαρμακευτικο παρασκευασμα για την διαγνωση και θεραπεια της στυτικης δυσλειτουργιας
US20050181030A1 (en) * 2003-01-03 2005-08-18 Mo Y. J. Topical stabilized prostaglandin E compound dosage forms

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51125142A (en) * 1974-06-27 1976-11-01 Ciba Geigy Ag Process for producing waterrinsoluble hydrophilic copolymer
JPS5256148A (en) * 1975-10-16 1977-05-09 Agency Of Ind Science & Technol Process for preparing active substances having improved

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3948254A (en) * 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
US3875300A (en) * 1972-12-18 1975-04-01 Ortho Pharma Corp Composition for sustained release of a medicament and method of using same
US3888975A (en) * 1972-12-27 1975-06-10 Alza Corp Erodible intrauterine device
US4036954A (en) 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
AR205997A1 (es) 1973-11-21 1976-06-23 American Cyanamid Co Resina de poliester normalmente solida biodegradable e hidrolizable
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
GB1554783A (en) 1976-01-05 1979-10-31 Population Res Inc Pharmaceutical compositions for use in the permanent sterilization of female animals
US4145555A (en) * 1976-03-12 1979-03-20 Ono Pharmaceutical Company Δ3 -Prostaglandin analogs
GB1551620A (en) * 1976-12-13 1979-08-30 Ici Ltd Delivery means for biologically active agents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51125142A (en) * 1974-06-27 1976-11-01 Ciba Geigy Ag Process for producing waterrinsoluble hydrophilic copolymer
JPS5256148A (en) * 1975-10-16 1977-05-09 Agency Of Ind Science & Technol Process for preparing active substances having improved

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5731607A (en) * 1980-06-20 1982-02-20 Crinos Industria Farmaco Spermicidal composition for local use
JPH01221318A (ja) * 1988-03-01 1989-09-04 Masao Igarashi ダナゾール含有の局所投与製剤
WO1993008804A1 (en) * 1991-11-08 1993-05-13 Kyoto Pharmaceutical Industries, Ltd. Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration

Also Published As

Publication number Publication date
DE3001454A1 (de) 1980-08-07
SE7910354L (sv) 1980-07-30
NO153520B (no) 1985-12-30
GB2041220B (en) 1983-07-27
DK160739C (da) 1991-09-30
GB2041220A (en) 1980-09-10
DK160740C (da) 1991-09-30
FR2447191B1 (en, 2012) 1983-07-22
US4352790A (en) 1982-10-05
DK33580A (da) 1980-07-30
NL190693B (nl) 1994-02-01
SE442167B (sv) 1985-12-09
NL8000426A (nl) 1980-07-31
DK160740B (da) 1991-04-15
NO800186L (no) 1980-07-30
DE3001454C2 (en, 2012) 1990-05-10
DK316186D0 (da) 1986-07-03
NL190693C (nl) 1994-07-01
DK160739B (da) 1991-04-15
NO153520C (no) 1986-04-09
DK316186A (da) 1986-07-03
JPH0140013B2 (en, 2012) 1989-08-24
SE431821B (sv) 1984-03-05
BE881351A (fr) 1980-05-16
SE7900737L (sv) 1980-07-30
FR2447191A1 (fr) 1980-08-22

Similar Documents

Publication Publication Date Title
JPS55102512A (en) Blend and its administration
YU135980A (en) Process for the manufacture of pharmaceutical formulations in the form of a polyacrylate film
JPS5581649A (en) Polymer composition for medical treatment and its preparation
ES386819A1 (es) Procedimiento para la obtencion de preparados ligadores delacido bilico.
KR900001362A (ko) 마이크로-입자 및/또는 나노-입자로 구성된 신규한 고체 다공성 단위형태 및 그것의 제조
NO152635C (no) Fremgangsmaate for fremstilling av cyklosporinholdige farmasoeytiske preparater i flytende form
FI900052A0 (fi) Kompositioner och behandlingsmetoder foer hemorrojder och annat.
AU557927B2 (en) Preparation of binderless 3a adsorbents use to dry h/c:s
SE8501370D0 (sv) Lagerstabila snabbsonderfallande farmaceutiska presstycken av verksamt material
NO172726C (no) Absorberende forbindingsmateriale eller hygieneprodukt i vannuopploeselig form
GR3026563T3 (en) Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method
NZ218948A (en) Pharmaceutical preparations containing viscous gels for administration by syringe
IL72897A0 (en) Preparation for the transdermal application of active substances,and processes for the preparation thereof
NO304217B1 (no) Geldannende, flytende kostfiberblanding, samt anvendelse av denne for fremstilling av et avf°ringsmiddel og et slankemiddel
IE790209L (en) Antacid formulation
EP0009609A3 (en) Adjuvant for promoting absorption of therapeutically active substances through the digestive tract, pharmaceutical composition comprising said adjuvant and process for preparing said pharmaceutical composition; enamine derivatives
KR900015768A (ko) 고형겔 외용약 전달 시스템
SE8103833L (sv) Spermiedodande komposition
SE7904307L (sv) Forfarande for framstellning av vattenolosliga absorptionsmedel
ES8703278A1 (es) Un procedimiento para cargar un polimero insoluble en agua yesponjable en agua con acetato de metilhidroxiprogesterona
DE3264331D1 (en) Aqueous preparation and its use in the preparation of ceramic masses
DE3782652D1 (de) Zubereitung zum stoppen von angiogenese und einem kapillar-, zellen- oder membranleck.
DE3066533D1 (en) Optically active cephalosporin analogs, process for their preparation and their use in the preparation of pharmaceutical compositions
ATE15329T1 (de) Pharmazeutische grundmasse und praeparate.
JPS5557520A (en) Preparation of carcinostatic substance